Industries Health CareHealth DiagnosticsMobileHeadquarters Regions San Francisco Bay Area, West Coast, Western US Founded Date 2000 Founders Alex Zettl, Garrett Gruener, Marvin L. Cohen Operating Status Active Last Funding Type Venture - Series Unknown
Stock Symbol OTCPINK:NNMX Company Type For Profit
Contact Email sales@nanomixdx.com Phone Number (510)428-5300
Nanomix's leadership in nano particle based electronic sensors has enabled the development of eLab, the next generation of Point of Care testing systems where superior performance and rapid results can both be achieved in virtually any setting. Assays run on eLab provide actionable diagnostic information in 10 minutes or less and can be used
to accelerate critical care or to make decisions to treat patients in place or transport them to the hospital. Use of mobile POC diagnostics is essential to reducing healthcare system costs while improving the patient experience and outcome. The Nanomix mobile diagnostic platform performs multiple in-vitro diagnostic and enzymatic assays simultaneously from a single whole-blood sample. The compact size of the electronic instrument and disposable test cartridge can be configured to run a wide variety of tests using muitple assay techniques. Initial system assays address critical cardiac care and sepsis screening.